Amazing...we could have the cure....not just a monitoring device...
Experimental studies showed that the delivery of an antisense drug against VLA-4 via inhalation to the lung significantly suppressed the key asthma indicators in allergen sensitized mice at very low inhaled doses, pointing to the potential new indication for ATL1102 as an inhaled treatment for asthma. The Company has conducted successful animal studies on this application of ATL1102 and is looking for a partner to continue the drug’s development in the asthma indication.
- Forums
- ASX - By Stock
- PER
- food for thought
food for thought, page-9
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.3¢ |
Change
0.002(2.47%) |
Mkt cap ! $74.82M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.2¢ | $9.57K | 112.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 124862 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 11000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 124862 | 0.081 |
4 | 62665 | 0.080 |
1 | 9500 | 0.078 |
2 | 40100 | 0.077 |
1 | 5000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 11000 | 1 |
0.090 | 105882 | 1 |
0.092 | 100000 | 1 |
0.093 | 46625 | 1 |
0.094 | 107837 | 1 |
Last trade - 15.56pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
8.2¢ |
  |
Change
0.002 ( 0.86 %) |
|||
Open | High | Low | Volume | ||
8.2¢ | 8.3¢ | 8.2¢ | 31700 | ||
Last updated 15.55pm 28/03/2024 ? |
Featured News
PER (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online